These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 23238591
1. Phase II prospective open-label trial of recombinant interleukin-11 in desmopressin-unresponsive von Willebrand disease and mild or moderate haemophilia A. Ragni MV, Novelli EM, Murshed A, Merricks EP, Kloos MT, Nichols TC. Thromb Haemost; 2013 Feb; 109(2):248-54. PubMed ID: 23238591 [Abstract] [Full Text] [Related]
7. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders. Nolan B, White B, Smith J, O'Reily C, Fitzpatrick B, Smith OP. Br J Haematol; 2000 Jun 15; 109(4):865-9. PubMed ID: 10929043 [Abstract] [Full Text] [Related]
8. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect. Castaman G, Federici AB, Bernardi M, Moroni B, Bertoncello K, Rodeghiero F. J Thromb Haemost; 2006 Feb 15; 4(2):357-60. PubMed ID: 16420565 [Abstract] [Full Text] [Related]
9. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP). Santiago-Borrero PJ, Casanova R. Bol Asoc Med P R; 1990 May 15; 82(5):207-10. PubMed ID: 2115785 [Abstract] [Full Text] [Related]
10. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A, Berneman Z, Schroyens W, Michiels JJ. Acta Haematol; 2009 May 15; 121(2-3):128-38. PubMed ID: 19506359 [Abstract] [Full Text] [Related]
12. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z. Acta Haematol; 2009 May 15; 121(2-3):119-27. PubMed ID: 19506358 [Abstract] [Full Text] [Related]
14. Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Mannucci PM, Bettega D, Cattaneo M. Br J Haematol; 1992 Sep 15; 82(1):87-93. PubMed ID: 1419807 [Abstract] [Full Text] [Related]
15. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management. Michiels JJ, van Vliet HH. Acta Haematol; 2009 Sep 15; 121(2-3):154-66. PubMed ID: 19506362 [Abstract] [Full Text] [Related]
19. Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process? Brown SA, Eldridge A, Collins PW, Bowen DJ. J Thromb Haemost; 2003 Aug 15; 1(8):1714-7. PubMed ID: 12911582 [Abstract] [Full Text] [Related]
20. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease. Castaman G, Lattuada A, Mannucci PM, Rodeghiero F. Br J Haematol; 1995 Jan 15; 89(1):147-51. PubMed ID: 7833254 [Abstract] [Full Text] [Related] Page: [Next] [New Search]